A novel ANK1 gene mutation associated with hereditary spherocytosis: a case report - Scorecard - MDSpire

A novel ANK1 gene mutation associated with hereditary spherocytosis: a case report

  • By

  • Mingqian Lai

  • Zhengqiang Luo

  • Zhenyu Yang

  • Ronghua Pan

  • Weijun Huang

  • Wensen Zhang

  • Guoda Ma

  • Riling Chen

  • May 29, 2026

  • 0 min

Share

Clinical Scorecard: Identification of a new ANK1 gene mutation linked to hereditary spherocytosis: a case study

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with hereditary spherocytosis, particularly in the Chinese population.
Care Setting

Key Highlights

  • additional_detail

Guideline-Based Recommendations

Diagnosis

    Management

    • criteria

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Clarify the type of preoperative vaccinations recommended.

        Clinical Best Practices

        • follow_up

        Related Resources & Content

        Original Source(s)

        A novel ANK1 gene mutation associated with hereditary spherocytosis: a case report

        • by Mingqian Lai, Zhengqiang Luo, Zhenyu Yang, Ronghua Pan, Weijun Huang, Wensen Zhang, Guoda Ma, Riling Chen

        • May 29, 2026

        Related Content

        The patients demanding unvaccinated blood transfusions

        Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study

        Crossing the line: blood transfusion thresholds in ECMO